ASX:CXLChemicals
Calix (ASX:CXL) Loss Widening To A$49.5m TTM Tests Bullish Growth Narrative
Calix (ASX:CXL) has reported its H1 2026 results with trailing 12 month revenue of A$31.0 million and a basic EPS loss of A$0.23, keeping the focus firmly on scale up rather than profitability at a current share price of A$1.08. Over recent halves the company has seen revenue move from A$12.0 million in H2 2024 to A$13.5 million in H1 2025 and A$14.7 million in H2 2025, while basic EPS losses narrowed from A$0.07 to A$0.03. This sets up this release as another checkpoint on whether higher...